Newsletter | May 6, 2025

05.06.25 -- Track Your Trial's Carbon Footprint Using A Sustainability Calculator

SPONSOR

Don’t miss the next Clinical Leader Solutions Expo—an interactive, multi-day event connecting you with top experts and innovative providers. Services Week, May 6–8, will spotlight patient recruitment and engagement, featuring tools and strategies to reach, retain, and support trial participants. We’ll also showcase CROs with oncology expertise, highlighting how they accelerate and streamline studies. Register only for the session(s) that match your interests.

CLINICAL TRIAL TECHNOLOGY

Track Your Trial's Carbon Footprint With This Sustainability Calculator

Pistoia Alliance Portfolio Lead Thierry Escudier discusses the latest updates to the Clinical Trial Carbon Calculator.

Achieving Best Outcomes With TMF Document Processing

TMF document processing requires a delicate balancing act. Sponsors strive for accuracy and completeness, but timeliness is crucial. How can teams achieve all three?

Using Tech Enabled Solutions To Boost Productivity And Sustainability

How can investing in suitable tech solutions enhance efficiency and reduce companies' carbon footprint?

Accelerate Respiratory Disease Trials: A Guide To Digital Endpoints

Learn how wearables and DHTs are alleviating the trial participation burden, increasing the likelihood of trial success, and enhancing the overall management of these conditions.

How Cloud ERP Overcomes Hidden Costs And Constraints

Explore how Cloud ERP systems provide businesses with the flexibility to scale and adapt quickly to market changes, as well as benefit from seamless updates without extensive customization.

Drive Superior Enrollment, Speed, And Quality Using eSource

Explore a detailed analysis of 140 research sites involved in a Phase III trial, highlighting significant advancements in trial performance and data quality using CRIO’s eSource platform.

Trial Planning Use Case

TA Scan, a web-based clinical intelligence tool, addresses challenges associated with the intricacies of trial planning by evaluating and ranking trial and site data.

EHR-To-EDC Success In A Complex, Adaptive Platform Trial

I-SPY 2, one of the longest-running adaptive platform trials in oncology, is revolutionizing breast cancer research through a dynamic, data-driven approach to evaluating novel therapies.

Connect With Clinical Leader: